Skip Navigation

First Doctorate-level Graduates from OU’s Occupational Therapy Program Enter Oklahoma Workforce

NEWS
Occupational Therapy doctoral graduates.
Occupational Therapy doctoral graduates pose for a picture at the OU-Tulsa graduation ceremony May 6, 2025. Photo credit: Ashley Hobson

First Doctorate-level Graduates from OU’s Occupational Therapy Program Enter Oklahoma Workforce


By

Bonnie Rucker

brucker@ou.edu

Date

May 22, 2025

OKLAHOMA CITY, OKLA. – The University of Oklahoma College of Allied Health celebrated the graduation of its first class of doctoral-level occupational therapy students this month. The OU program is the first accredited occupational therapy doctoral program in the state of Oklahoma. The program, which serves students in Oklahoma City and Tulsa, was recently changed from a master’s program to a doctoral program in order to widen opportunities for graduates in the future.

“We wanted our graduates to have the option to do more than serve in clinical roles,” said Mary Isaacson, recently retired OT program director who led the initial change. “We envisioned them as leaders and educators addressing Oklahoma’s growing community needs. Moving to a doctoral program was a natural fit, aligning with national trends and preparing students to practice at the top of their license in both traditional and emerging settings.”

The American Occupational Therapy Association has emphasized the importance of occupational therapists working in unconventional settings such as mental health facilities and nonprofit work. This higher level of license enables OU graduates to fill these positions and pursue additional research and academic opportunities, equipping them to become leaders in their field.

Research and leadership training are a significant part of what sets an OT doctoral degree apart from a master's degree. Postgraduate students spend time focusing on research and learning what it takes to not only practice clinically, but to lead other practitioners.

“Clinically doctoral students are trained in the same way as master's students are. However, where it differs is in that next level of thinking,” said Jerilyn Callen, new director of the occupational therapy program at OU. “Through this program, they are prepared to become directors and open their own clinics because they’ve spent time researching and watching other professionals who have done that very thing.”

Heidi Young, occupational therapy graduate who served as class president for the first graduating class of doctoral level students, describes how her experience with the enhanced program helped her grow. She related how the experience included challenges and opportunities in navigating a new normal for students, faculty and staff, but that, ultimately, it has shaped her into a capable and resilient practitioner.

“The combination of rigorous research and hands-on clinical training has made me a more well-rounded and confident practitioner, better prepared to thrive after graduation,” Young said.

About the University of Oklahoma

Founded in 1890, the University of Oklahoma is a public research university located in Norman, Oklahoma. As the state’s flagship university, OU serves the educational, cultural, economic and health care needs of the state, region and nation. For more information about the university, visit www.ou.edu.


Recent News

Campus & Community
April 16, 2026

Jennings Accepted Into National Leadership Program

University of Oklahoma College of Medicine Associate Professor Lee Jennings, M.D., chief of the Division of Geriatrics and Palliative Medicine in the Department of Internal Medicine, has been selected for the Hedwig van Ameringen Executive Leadership in Academic Medicine® (ELAM) program, one of the nation’s top leadership fellowships in academic health care.


Campus & Community
April 15, 2026

OU Community Comes Together for Giving Day 2026

The University of Oklahoma community came together once again in a powerful show of generosity during its annual Giving Day, raising over $29.6 million to support causes university-wide.


Research
April 14, 2026

Experimental Drug Offers Hope for Patients with Advanced Pancreatic Cancer

Results from a Phase 3 clinical trial offer new hope for patients with advanced pancreatic cancer, showing the experimental drug daraxonrasib significantly extended survival compared with chemotherapy alone. Researchers at the University of Oklahoma Health Stephenson Cancer Center enrolled patients in the global trial.